Amedisys Cash Flow - Quarterly (NASDAQ:AMED)

Add to My Stocks
$49.17 $1.79 (3.51%) AMED stock closing price Aug 17, 2017 (Closing)

The financial analysis of AMED requires an investor to check the cash flows for Amedisys. The profit-loss statement shows Amedisys profits, the balance sheet shows Amedisys debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Amedisys stock analysis shows positive net income cash flow of $19.73M for 2017-Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   Amedisys saw a outflow of $23.28M from investing activities for 2017-Q2. View details of Amedisys cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Amedisys Net Income Cash Flow
19.73M15.19M37.63M28.65M17.15M6.31M-2.31M-15.38M-23.95M-34.83M
Depreciation Depletion Amortization Cash-Flow9.32M4.6M20.41M15.21M9.81M4.65M20.99M16.57M86.89M82M
Net Increase (Decrease) in Assets Liabilities1.8M-14.83M-67.07M-59.08M-31.4M-13.24M-18.34M-2.42M-3.26M-16.58M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net32.49M22.12M71.28M48.91M31.32M14.51M107.44M88.98M-2.63M-16.1M
Amedisys Net Cash from (used by) Operating Activities
63.34M27.09M62.25M33.69M26.89M12.24M107.78M87.74M57.03M14.48M
Increase (Decrease) in Prop Plant And Equipment-7.45M-4.38M-15.71M-13.5M-9.68M-6.7M-1.44M-17.96M-15.64M-2.11M
Acquisition Disposition of Subsidiaires-24.13M-4.09M-35.52M-31.37M-27.63M-27.68M-68.71M-5.38M--
Increase (Decrease) in Investments-0.44M-0.25M-1.04M-0.75M-0.43M-1.51M2.43M3.83M-
Other Cash Inflow (Outflow) from Investment Activities0.57M0.56M0.23M0.23M-0.23M1.22M1.05M-0.01M0.04M
Amedisys Net Cash from (used by) Invesment Activities
-31.45M-8.17M-52.04M-45.4M-37.75M-34.15M-67.42M-19.85M-11.82M-2.06M
Issuance (Purchase) of Equity Shares-0.34M0.5M-9.83M-10.49M-11.1M-11.67M-1.97M1.99M1.25M0.68M
Issuance (Repayment) of Debt Securities-2.5M-1.25M-5M-3.75M-2.5M-1.25M-3M-3M-6M-3M
Increase (Decrease) in Bank & Other Borrowings-----15M-15M-15M-15M-15M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.09M-0.04M7.31M7.36M6.93M0.15M-0.91M-2.85M-0.3M-
Amedisys Net Cash from (used by) Financing Activities
-2.93M-0.78M-7.51M-6.88M-6.67M2.23M-20.89M-18.86M-20.04M-17.31M
Effect of Exchange Rate Changes on Cash----------
Amedisys Net Change in Cash & Cash Equivalents
28.97M18.13M2.69M-18.58M-17.53M-19.67M19.47M49.01M25.16M-4.9M
Cash & Equivalents at Beginning of Year27.5M8.03M17.3M14.54M48M120.29M34.48M2.84M56.19M84.22M
Cash & Equivalents at Year End59.16M48.33M30.19M8.91M9.96M7.82M27.5M57.05M33.2M3.13M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

1:23
AMED
Amedisys stock price history provides insight into historical stock price fluctuations, and Amedisys stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
  • Net Change in Cash and Cash Equivalents: Amedisys cash grew QoQ to $19.73M, meaning the company is able to meet its expenditure and grow cash which will also eventually reflect in the Amedisys stock price movement.
  • Amedisys increased its cash from operating activities to $36.25M in 2017-Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $63.34M for AMED in last quarter report.
  • Cash flow from financing activities shows the flow of cash between Amedisys and its owners and creditors and was $-2.93M for 2017-Q2. Financing activities allow a company to raise capital, and repay bondholders.
.

Key Financial Ratios For Amedisys Cash Flow

FCF margin
0.09